Medical professionals have been using artificial intelligence (AI) to streamline diagnoses for decades, using what are called diagnostic decision support systems (DDSSs). Computer scientists at Massachusetts General Hospital (MGH), a founding member of the Mass General Brigham healthcare system first developed MGH’s own DDSS called DXplain in 1984, which reliesContinue Reading
luza studios/E+ via Getty Images Digital Realty Trust (NYSE:DLR) and Equinix (NASDAQ:EQIX) perked up 2.8% and 2.7%, respectively, in Thursday morning trading as Mizuho analyst Vikram Malhotra started coverage of the REITs with Outperform ratings on the view that “solid fundamentals for data centers are set to get even better.”Continue Reading
phototechno/iStock via Getty Images Keefe, Bruyette & Woods upgraded PennyMac Mortgage Investment Trust (NYSE:PMT) shares to Outperform from Market Perform in a recent note on the expectation that return on equity will continue to increase should it keep deploying capital in mortgage servicing rights (MSRs). PMT gained 2.6% minutes afterContinue Reading
Assured Guaranty stock (NYSE:AGO) rose 3.78% after brokerage firm KBW upgraded it to Outperform from Market perform, citing that the company’s valuation at 0.70x year-end book looks very compelling. The stock was trading at $79.60 in the morning on Tuesday. AGO had risen 41.16% in the last 12 months. TheContinue Reading
peterschreiber.media Mizuho started coverage of Neumora Therapeutics (NASDAQ:NMRA) with an outperform rating, stating it sees 50%+ upside to the stock if the company reports positive Phase 3 data for its lead drug navacaprant in the treatment of major depressive disorder. The investment bank noted the Phase 3 data is expectedContinue Reading
JHVEPhoto Intuit (NASDAQ:INTU) was in the spotlight on Wednesday as investment firm RBC Capital Markets started coverage on the Turbo Tax maker, citing its successful transition to subscriptions, opportunity from artificial intelligence and rising margins. Shares were little changed in premarket trading. Although roughly 80% of the company’s revenue comesContinue Reading
Investing.com — Despite the buzz around the exchange-traded funds (ETFs) in the second quarter, the digital assets landscape saw mixed performance, with crypto assets lagging behind more traditional assets, broker Canaccord Genuity stated in a research report on Monday. Despite major events such as the Bitcoin halving and the SEC’sContinue Reading
Dmitry Vinogradov Scotiabank has initiated Myriad Genetics at outperform as it is trading at a discount to other advanced diagnostics companies and the markets it is focused on are under penetrated. The firm has a $29 price target (~18% upside based on June 26 close). Analyst Sung Ji Nam notedContinue Reading
sefa ozel/E+ via Getty Images Kyndryl Holdings’ (NYSE:KD) stock rose about 2% on Thursday after Oppenheimer initiated coverage with an Outperform rating. The firm has set a $33 price target on shares of the company, which provides IT infrastructure and cloud services. Analysts led by Ian Zaffino noted that, withContinue Reading
Olemedia/E+ via Getty Images Arcadium Lithium (NYSE:ALTM) +12.7% in Wednesday’s trading as RBC Capital rates the stock as a new Outperform with a $4 price target, saying the company offers investors “the most vertically integrated, and diversified lithium and chemical exposure across our coverage.” The RBC team sees production growthContinue Reading
